Verification of patient set-ups using the electronic portal imaging system

Articles > Article · 2021

Authors: Özlem Bağcı Çelik, Hakan EREN, Murat KÖYLÜ, Nezahat OLACAK, AYFER HAYDAROĞLU

Journal of Medicine and Applied Science, Other Refereed National Journals, National, 2021, vol 1, pp 36-41

Summary

<p><b><span style="left: 368.083px; top: 452.426px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.17389);">Abstract</span></b></p><p><span style="left: 368.083px; top: 452.426px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.17389);"><br></span><span style="left: 368.083px; top: 480.476px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.99959);">While set</span><span style="left: 429.083px; top: 480.476px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 434.483px; top: 480.476px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.05233);">up uncertainties in patient positioning may result in </span><span style="left: 781.367px; top: 480.476px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.05978);">inadequate treatment of the </span><span style="left: 368.083px; top: 498.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.987569);">tumor, increasing the likelihood of local tumor recurrence, some non</span><span style="left: 837.767px; top: 498.676px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 843.167px; top: 498.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.984545);">target tissues may </span><span style="left: 368.083px; top: 516.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.01106);">be over</span><span style="left: 420.683px; top: 516.676px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 426.083px; top: 516.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.99809);">irradiated. Random and systematic set</span><span style="left: 692.917px; top: 516.676px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 698.317px; top: 516.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.995435);">up errors were investigated using DRR </span><span style="left: 368.083px; top: 534.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.990609);">(Digitally Reconstructed Radiograph) images of the plans</span><span style="left: 765.517px; top: 534.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.00004);">of 15 lung, 21 head</span><span style="left: 904.567px; top: 534.876px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 909.967px; top: 534.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.00381);">neck, 10 </span><span style="left: 368.083px; top: 552.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.04836);">pancreatic, 15 breast, 4 stomach and 33 pelvic region cancer patients treated with three</span><span style="left: 962.967px; top: 552.876px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 368.083px; top: 571.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.03562);">dimensional conformal radiotherapy technique in our clinic. The highest systematic set</span><span style="left: 946.367px; top: 571.076px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 951.767px; top: 571.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.074);">up </span><span style="left: 368.083px; top: 589.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.04421);">error was 5.29 mm medial</span><span style="left: 546.883px; top: 589.076px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 552.283px; top: 589.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.05761);">lateral in lung cancer</span><span style="left: 699.917px; top: 589.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.04136);">patients, cranio</span><span style="left: 803.167px; top: 589.076px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 808.567px; top: 589.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.0689);">caudal with 5.53 mm in </span><span style="left: 368.083px; top: 607.276px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.05469);">patients with head and neck cancer, medial</span><span style="left: 662.717px; top: 607.276px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 668.117px; top: 607.276px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.07719);">lateral with 4.22 mm in patients with gastric </span><span style="left: 368.083px; top: 625.476px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.02762);">cancer, and medial</span><span style="left: 503.083px; top: 625.476px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 508.483px; top: 625.476px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.05997);">lateral with 6.20 mm in patients with pancreatic cancer. in the </span><span style="left: 368.083px; top: 643.476px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.04847);">anterior</span><span style="left: 419.483px; top: 643.476px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 424.883px; top: 643.476px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.06186);">posterior direction with 5.02 mm i</span><span style="left: 653.317px; top: 643.476px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.05235);">n regional cancers and 7.0 mm in the anterior</span><span style="left: 962.967px; top: 643.476px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 368.083px; top: 661.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.03201);">posterior direction in breast cancer patients. The highest random set</span><span style="left: 824.567px; top: 661.676px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 829.967px; top: 661.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.0307);">up error was medial</span><span style="left: 962.967px; top: 661.676px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 368.083px; top: 679.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.0674);">lateral with 5.98 mm in lung cancer patients, anterior</span><span style="left: 729.117px; top: 679.676px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 734.717px; top: 679.676px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.06897);">posterior with 9.05 mm in patients </span><span style="left: 368.083px; top: 697.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.969471);">with head and neck cancer, med</span><span style="left: 591.317px; top: 697.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.05857);">ial</span><span style="left: 606.117px; top: 697.876px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 611.517px; top: 697.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.984362);">lateral with 4.52 mm in patients with gastric cancer, </span><span style="left: 368.083px; top: 715.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.0501);">and 6.00 mm in cranio</span><span style="left: 520.483px; top: 715.876px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 525.883px; top: 715.876px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.06123);">caudal and pelvic in patients with pancreatic cancer. It was in the </span><span style="left: 368.083px; top: 734.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.0035);">cranio</span><span style="left: 408.283px; top: 734.076px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 413.683px; top: 734.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.06361);">caudal direction with 9.79 mm in regional cancers and in the cranio</span><span style="left: 920.367px; top: 734.076px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 925.767px; top: 734.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.01011);">caudal </span><span style="left: 368.083px; top: 752.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.02305);">direction with 5.96 mm in </span><span style="left: 557.317px; top: 752.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.00482);">breast cancer patients. Clinically, pre</span><span style="left: 812.767px; top: 752.076px; font-size: 15px; font-family: sans-serif;">-</span><span style="left: 818.167px; top: 752.076px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.0332);">treatment and weekly </span><span style="left: 368.083px; top: 770.276px; font-size: 15px; font-family: sans-serif; transform: scaleX(1.04647);">electronic portal imaging were found to be sufficient to control treatment area accuracy in </span><span style="left: 368.083px; top: 788.309px; font-size: 15px; font-family: sans-serif; transform: scaleX(0.971892);">all cancer cases.</span></p>

View details